Group 1 - Wynn Macau's parent company, Wynn Resorts, Limited, reported a revenue of approximately $127 million for its Macau operations in Q1 2025, a year-over-year decrease of 38.27% [1] - Adjusted property EBITDAR for Wynn Macau in Q1 2025 was about $25.2 million, down 25.76% compared to the previous year [1] - The operating revenue for Wynn Palace in Q1 2025 was $535.9 million, a decrease of $51 million from $586.9 million in Q1 2024 [1] Group 2 - Wynn Macau's operating revenue for Q1 2025 was $330 million, down $81.8 million from $411.7 million in Q1 2024 [2] - Adjusted property EBITDAR for Wynn Macau in Q1 2025 was $90.2 million, compared to $137.2 million in Q1 2024 [2] - The percentage of table win for the mass market was 18.7% in Q1 2025, lower than 19.4% in Q1 2024 [2]

SAN FRANCISCO and SUZHOU, China, May 6, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces the completion of first patient dosing in the Phase 2 clinical study of efdamrofusp alfa (R&D code: IBI302), a recombinant human vascular endothelial growth factor r ...

在商业化拓展方面，神州控股旗下公司凭借覆盖全国的2600多个集成服务网点及端到端一站式的数据智 能解决方案能力，近期连续中标签约长春一汽和上汽通用五菱，为其工厂及4S店网点提供IT终端运维治 理、算力规划与咨询、集成方案设计与实施等服务，助力其提高工作效率、降低运营成本，并优化资源 配置。 神州控股通过集成服务网点，将标准化的服务和解决方案进行跨地域、跨行业复制的模式，为连锁业态 的数字化转型提供了强大助益。此番连续中标签约车企，表明这一模式获得了市场充分验证。基于长春 一汽、上汽通用五菱等头部车企的标杆效应，神州控股将加速在汽车行业的复制推广，拓展更多市场空 间。 中长期看，随着中国加快建设数字中国、持续推进"人工智能+"行动及支持大模型广泛应用，数字要素 市场与AI场景应用快速发展，将为神州控股提供广阔市场机遇。公司表示，未来将进一步聚焦数据要 素价值释放与AI场景化应用战略，立足于行业聚焦、技术驱动、生态协同及精益管理四项发展举措， 持续推动数据+AI业务创新发展，赋能更多行业的数智化转型。 在智慧供应链领域，神州控股旗下5A级物流企业科捷，深耕20多年，凭借技术优势在IT、通讯、消费 等行业长期处于领 ...

（本报莫斯科5月6日电） "俄中关系不断巩固，双边合作成果惠及两国民众。"中俄友好、和平与发展委员会生态理事会俄方主席 奥列格·杰里帕斯卡日前在接受本报记者采访时表示，俄中务实合作发展迅速，涵盖领域广泛，两国在 贸易和投资方面合作潜力巨大。 杰里帕斯卡表示，在俄中双方共同努力下，两国合作规模不断扩大，保持了量稳质升的良好态势。近年 来，中国在绿色发展领域取得显著成就，尤其是在光伏、风电等领域取得了长足发展，拥有丰富的可再 生能源和全球最大的电动汽车市场及上下游配套产业链，成为全球能源投资领域的领先者。 杰里帕斯卡表示，中国提出的"双碳"目标促进了私营经济对绿色领域的投资，这一经验非常有启示意 义。"中国环保事业目标明确、措施科学全面有力，给世界其他国家带来启发。"他说，"俄罗斯可以学 习中国供给侧结构性改革经验，促进成熟绿色能源市场的形成。俄中绿色低碳领域合作潜力巨大。" 近年来，中俄教育合作蓬勃发展。两国留学生数量不断增加，俄罗斯青年学习中文的热情越来越高。两 国文化交流活动如火如荼，中俄友好、和平与发展委员会2月28日在中国西安举行了俄罗斯"送冬节"庆 祝活动。杰里帕斯卡致力于将莫斯科大剧院等俄罗斯优秀演 ...

特此公告。 丽珠医药集团股份有限公司董事会 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000513、01513 证券简称：丽珠集团、丽珠医药 公告编号：2025-039 丽珠医药集团股份有限公司 关于2022年股票期权激励计划部分股票期权注销完成的公告 本公司及董事会全体成员保证信息披露内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 丽珠医药集团股份有限公司（以下简称"公司"）于2025年4月23日召开了第十一届董事会第二十四次会 议，审议通过了《关于注销2022年股票期权激励计划部分股票期权的议案》，同意对公司2022年股票期 权激励计划首次授予第一个行权期内31名激励对象到期尚未行权的38.4045万份股票期权予以注销；因 公司首次授予股票期权第三个行权期及预留授予股票期权第二个行权期对应公司层面业绩考核目标不达 标，同意对2022年股票期权激励计划首次授予股票期权第三个行权期对应的528.3750万份和预留授予股 票期权第二个行权期对应的100.00万份股票期权进行注销。有关详情请见公司于2025年4月24日在《中 国证券报》《证券时报》《证券日报》《上海证券报》及巨潮资 ...

证券代码：601077 证券简称：渝农商行 公告编号：2025-022 重庆农村商业银行股份有限公司关于2024年度股东大会增加临时提案的公告 本行董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性承担法律责任。 一、股东大会有关情况 1.股东大会的类型和届次： 2024年度股东大会 2.股东大会召开日期：2025年5月21日 3.股权登记日 ■ 二、增加临时提案的情况说明 三、除了上述增加临时提案外，于2025年4月26日公告的原股东大会通知审议事项不变。 四、增加临时提案后股东大会的有关情况。 1.提案人：重庆渝富资本运营集团有限公司、重庆市城市建设投资（集团）有限公司、重庆发展置业管 理有限公司 2.提案程序说明 本行已于2025年4月26日公告了股东大会召开通知，分别单独持有8.70%、7.02%、5.19%股份的股东重 庆渝富资本运营集团有限公司、重庆市城市建设投资（集团）有限公司、重庆发展置业管理有限公司， 在2025年5月6日提出临时提案并书面提交股东大会召集人。股东大会召集人按照《上市公司股东会规 则》有关规定，现予以公告。 3.临时 ...

Core Insights - Shanghai Junshi Biosciences Co., Ltd. (复宏汉霖) has successfully transitioned from a pre-profit biotech firm to a profitable entity, achieving a net profit of 546 million yuan in 2023 and a 50.3% year-on-year growth to 820 million yuan in 2024, marking it as the first company to achieve full profitability under the Hong Kong Stock Exchange's Chapter 18A for pre-profit biotech firms [1][3][6] Group 1: Business Strategy - The company has adopted a differentiated and global strategy, rapidly commercializing its innovative products and establishing a significant presence in the global market [1][3] - Junshi's innovative drug, Hanshu, has become the first and only product in the EU to potentially secure a market exclusivity period of up to 10 years [1][6] - The company has successfully launched four products in over 50 countries, reaching 750,000 patients by the end of 2024 [1][8] Group 2: R&D and Innovation - Junshi has focused on high-risk, differentiated indications for drug development, targeting less crowded markets such as small cell lung cancer and gastric cancer [5][6] - The company is advancing its PD-L1 targeted antibody-drug conjugate (ADC) project, HLX43, which is the second globally to enter clinical trials, exploring efficacy against five solid tumors [4][5] - AI technology is being utilized to shorten R&D timelines and reduce costs, with successful projects including the development of a second-generation hyaluronidase [7][8] Group 3: Global Expansion - Junshi has submitted 25 registration applications globally in 2024, receiving 17 approvals across various regions including China and the US [6][8] - The company has established a strong international presence, with a focus on markets in the US, EU, Japan, Southeast Asia, the Middle East, and Latin America [6][8] - Collaborations with global partners such as Abbott and Dr. Reddy's are being pursued to enhance early pipeline development and create a collaborative ecosystem [7][8]

Group 1 - The core viewpoint of the news is that SF Express has launched an innovative unmanned vehicle delivery service in collaboration with KFC in Shenzhen, enhancing delivery efficiency through a "unmanned vehicle + rider" model [2] - The unmanned vehicle has a total volume of 5.5 cubic meters and can operate 100% autonomously in extreme weather conditions, handling complex scenarios such as steep underground parking and traffic congestion [2] - The partnership aims to expand the application of unmanned vehicles in the food delivery sector, with future plans to extend services to semi-enclosed or hard-to-reach areas like campuses and parks [2] Group 2 - SF Express reported a revenue of 15.756 billion yuan for 2024, representing a year-on-year increase of 27.1% [3] - The gross profit surged by 34.8% to 1.071 billion yuan, while the net profit attributable to shareholders reached 132 million yuan, marking a year-on-year growth of 161.8% [3] - The company achieved a net cash inflow from operating activities of 272 million yuan for the year, indicating strong business quality and operational resilience [3]

韩国外交部：韩国外长和美国外长通话，讨论了经济合作问题。 ...